News | September 12, 2024
AGC and Medinet sign agreement for cell therapy CDMO business
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Konieczny has served as Interim CEO since April 2024
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
This project is supported by the Irish Government through IDA Ireland
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
GSK and Flagship to jointly fund up to $150 million upfront
Report highlights significant improvements in adolescent well-being in India
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
Subscribe To Our Newsletter & Stay Updated
